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ABSTRACT 
In this research study an attempt was made to formulate sustained release matrix tablets of Metformin Hydrochloride as it possesses relatively 
shorter plasma half-life, low bioavailability. The sustained release formulations of the drug were capable of maintaining the plasma level for 8-
12 hours. The overall objective of this research was to formulate the tablet by using various hydrophilic polymers i.e. Xanthan gum, Guar gum, 
Aloe barbadensis and Methocel K4M. Tablets were prepared by wet granulation method. In Vitro studies were performed by USP XX  apparatus 
I, basket and the data was analyzed using zero order, first order, and Korsmeyer and Higuchi models. Nine formulations were made, out of 
which F-9 formulation which was composed of Aloe Barbadensis in the ratio of 1:2, with combination of other polymers (xanthan gum, gu ar 
gum and methocel K4 M) showed maximum drug release within 12 hours with sustained release profile because Aloe barbadensis showed 
maximum swelling followed by entanglement of polymers chains, thus gave maximum gel strength which provides main retarding factor for the 
drug release. The use of three polymers (xanthan gum, guar gum and methocel K4M) alone in the different formulations i.e. from F-1 to F-6 was 
not able to sustain the drug release because of their rapid solubilization in acidic pH leads to pores in the matrix, finally  causes surface erosion 
and initial disaggregation of the matrix tablet prior to gel layer formation around tablet core causes rapid release of the drug within 1 hour as 
compared to F-9 formulation.  
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INTRODUCTION 
The sustained release dosage form are designed in such a 
way that they continuously release the drug over an 
extended period of time after the administration of a single 
dose of a dug. The basic goal of this therapy is to provide a 
steady state blood or tissue level which is both 
therapeutically effective and non-toxic for prolonged period 
of time and finally improves patient compliance as well as 
toxicity to a large extent. The basic rational of sustained drug 
delivery system is to alter the pharmacokinetics and 
pharmacodynamics of the pharmacologically active drug 
moieties by modifying their molecular structure or 
physiological parameters. Basically a sustained release oral 
dosage form is designed to rapidly release pre-determined 
fraction of the total dose (loading dose) into gastrointestinal 
tract, which will produce the desired pharmacological 
response as promptly as possible and the remaining fraction 
of the total dose (maintenance dose) is then released at a 
controlled rate to maintain the steady state. The controlled 
release of the drug product is designed so that the release 
rate of maintenance dose is equal to the elimination rate. 
The constant blood levels can be achieved from controlled 
release system and the prolonged release of the dosage form 
reduces the fluctuation in plasma by slowing down its 
absorption rate so that its slower drug release rate can be 
achieved as well as can be maintained [3 - 5]. 
Metformin hydrochloride is an orally administered 
biguanide which is used in the management of type-II 
diabetes, a disease that combines defects of both insulin 
secretion and insulin action. Metformin HCl does not causes 
hypoglycemia at any reasonable dose, thus it is called as an 
antihyperglycemic rather than a hypoglycemic drug. It is a 
hydrophilic drug which is slowly as well as incompletely 
absorbed from the gastrointestinal tract, and the absolute 
bioavailability is reported to be of 50-60 %.  Metformin HCl 
has relatively short plasma half-life of 1.5-4.5 hours and the 
low absolute bioavailability of 50-60 %. The side effects, 
short half-lives, low bioavailability makes the administration 
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two to three times a day when larger doses are required 
which can decrease patient compliance, thus sustained 
release products are needed for metformin which can 
prolong its duration of action, improve patient compliance 
and reduces toxicity of drug in the body . The natural gums 
are widely used in the preparation of sustained release 
tablets. Xanthan gum, Guar gum and Aloe Vera were the 
natural gums used in this research work. Xanthan gum are 
obtained from Xanthomonas campestris. Guar gum is 
derived from guar plant Cyamopsis tetragonolobus (i.e. 
Cluster bean), finds wide application as stabilizer and 
thickener in pharmaceutical industry. Aloe Vera is obtained 
from the mucilage of leaves of Aloe barbadensis. These 
natural gums are reported to have antidiabetic effect on 
humans which helps to potentiate the effect of Metformin 
HCl. The use of these hydrophilic polymers alone for the 
purpose of extending drug release for the highly water 
soluble drugs is restricted due to rapid diffusion of the 
dissolved drug through its gel network. It was found that 
dried mucilage of Aloe barbadensis can potentiate the 
antidiabetic effect to a great extent as well provides 
maximum sustained effect because of its excellent gelling 
strength [6, 7]. 
The main objective of the present work was to formulate the 
drug, Metformin with various hydrophilic natural and 
synthetic polymers alone or in combination. As according to 
BCS classification Metformin falls under the category III 
(High solubility and low permeability). The high solubility is 
the main obstacle for its sustained action and high 
bioavailability but low permeability potentiates its sustained 
action. The use of various natural polymers provides pH 
independent drug release. Aloe barbadensis was chosen to 
be best fit polymer for retarding the drug release with 
combination of other used polymers such as xanthan gum, 
guar gum and methocel K4M. These polymers used alone 
cause’s sudden burst release of drug because of their rapid 
solubilization in acidic pH and initial disaggregation of drug 
particles before the gel formation of the used hydrophilic 
polymer. Tablets were prepared by wet granulation method; 
this method is a process of forming granules by binding the 
powders together with an adhesive rather than compaction. 
Liquid bridges are formed between particles and tensile 
strength of these blends increases with the amount of liquid 
binder. Surface tension and capillary forces are responsible 
for initial granule formation and their strength. Granules are 
said to have improved free flowing properties as well as 
decreased dust problems. Various excipients used such as 
Microcrystalline Cellulose which is most increasingly used in 
formulating sustained release dosage forms for the matrix 
tablet drug delivery. Hydrophilic polymers are included 
necessarily in tablets in order to form a viscous, gelling layer 
which helps to retard the water penetration and acts as a 
barrier to drug release. The majority of drug release occurs 
by diffusion through and erosion of this barrier [7].  
MATERIALS AND METHODS 
Materials  
Metformin HCl was obtained as a gift sample from Swiss 
Garnier Life Sciences Mehatpur, Himachal Pradesh. 
Microcrystalline cellulose, Aerosil, Talc were also obtained 
from Swiss Garnier Life Sciences Mehatpur, Himachal 
Pradesh. Xanthan gum, Guar gum was obtained from Dabur 
Pharmaceuticals, Haridwar. Aloe barbadensis was obtained 
from Botanical garden of Shivalik College of Pharmacy, 
Nangal. 
 
Methods  
Preformulation Studies 
Preformulation studies is described as the method of 
optimizing the delivery of drug by determining the 
physiochemical properties of the active compound that can 
affect drug performance as well as development of an 
efficacious, stable and safe dosage form [1]. 
Physical appearance 
The drug metformin hydrochloride was visually observed 
and was found to be 
Color: White hygroscopic crystalline powder. 
Odor: Odorless 
Taste: Bitter taste. 
Determination of    max 
The absorption maxima of Metformin Hydrochloride was 
scanned between 200-400nm. The  max of the drug was 
determined by UV- visible spectrophotometric method to 
obtain the structural information regarding the 
chromophoric part of Metformin Hydrochloride. 
Preparation of calibration curve of Metformin in 
Phosphate buffer of pH 6.8  
Metformin Hydrochloride concentration in the solution was 
determined by UV- Visible spectrophotometer by reading 
the instrument at 233nm. The standard curves of Metformin 
Hydrochloride were prepared in water and phosphate buffer 
pH 6.8.100mg of Metformin Hydrochloride was correctly 
weighed and transferred in to 100ml of standard flask and 
then volume was made up to 100ml with the phosphate 
buffer. Pipette out 1ml again from the prepared solution and 
this will serve as stock solution for the dilution make up. 
Finally the dilutions were made by pipetting out 1ml, 2ml, 
3ml, 4ml and 5ml from the stock solution, and further they 
were diluted to 10ml with phosphate buffer with pH 6.8. 
Fourier- Transform Infrared Spectroscopy (FTIR) 
IR spectroscopy is the best technique for qualitative 
compound identification. It gives information about the 
group present in the particular compound. IR study was 
performed for identification and structural analysis of the 
procured drug using Shimadzu- 1800 FTIR. The potassium 
bromide (KBr) disk technique was employed using 100mg of 
spectroscopic grade dried KBr. KBr was ground into a fine 
powder using a mortar/pestle and compressed into disc 
under hydraulic pressure at 10,000psi. Metformin 
Hydrochloride and drug excipient mixture were placed on 
the KBr disc with the help of capillary tube. Each KBr disc 
was scanned at a resolution of 400 cm-1 and characteristic 
bands were recorded. 
Solubility 
The solubility of a drug in a specific solvent is measured in 
terms of saturation solubility.  
Table 1: Solubility profile for metformin hydrochloride 
in water, isopropyl alcohol, methylene chloride, ethanol 
and acetone are: 
S. No.                Solvent               Solubility 
1. Water Freely soluble 
2. Isopropyl alcohol Freely soluble 
3. Methylene chloride Freely soluble 
4. Ethanol Slightly soluble 
5. Acetone Not soluble 
 
Sharma et al                                                                                                         Journal of Drug Delivery & Therapeutics. 2019; 9(3-s):374-385 
ISSN: 2250-1177                                                                                   [376]                                                                                     CODEN (USA): JDDTAO 
Saturation solubility is the extent of solubility of the drug 
beyond which addition of any more amount of solute does 
not increase concentration of solution. The solubility of 
Metformin HCl was tested in various solvents. A definite 
quantity (10 mg) of drug was dissolved in 10ml of each 
investigated solvent and shaken at 25°C for 24 hours in a 
water bath shaker until the equilibrium was obtained. 
Melting point  
Melting point of the drug was determined by capillary fusion 
method; one sided closed capillary filled with drug and put 
into the Melting point apparatus. Temperature was noted at 
which drug converts into liquid. 
 
Table 2: Melting point of metformin hydrochloride 
    Reported value            Experimental value            Mean value 
          224°C 223°C 224°C 224°C              224°C 
 
Various Pre compression parameters 
Bulk density 
It is defined as the ratio of total mass of powder to the bulk 
volume of powder. It is calculated by pouring the weighed 
powder (passed through standard sieve # 20) into a 
measuring cylinder and initial weight was noted. This initial 
volume was called the bulk volume. From this the bulk 
density was calculated according to formula mentioned 
below. It is expressed in gm/ml is given by 
Bulk density= M/Vb 
Where, M and Vb are mass of powder and bulk volume of the 
powder respectively [12]. 
Tapped density 
Tapped density is defined as the ratio of total mass of the 
powder to the tapped volume of the powder. Volume of 
powder was measured by tapping the powder for 750 times 
and the tapped volume was noted if the difference between 
these two volumes is less than 2%. If it is more than 2%, 
tapping is continued for 1250 times and tapped volume was 
noted. Tapping was continued until the difference between 
successive volumes was found to be less than 2% (in a bulk 
density apparatus). It is mainly expressed in the units of 
gm/ml and is given by. 
Tapped density = M/Vt 
Compressibility index 
The compressibility index of the powder was determined by 
Carr’s compressibility index [12]. 
Carr’s index (%) = Tapped density-Bulk density/Tapped 
density×100 
Hausner ratio 
Bulk density and tapped density were first calculated and 
finally Hausner’s ratio was calculated. It indicates the flow 
properties of the granules and is calculated by taking the 
ratio of tapped density to the bulk density. Hausner’s ratio is 
an indirect index for the ease of powder flow. It is calculate 
by the given formula [12]. 
Hausner ratio= Tapped density /Bulk density 
Lower Hausner’s ratio (<1.25) indicates better flow 
properties than high ones (>1.25). 
Angle of Repose 
Angle of repose of pure drug was determined by using fixed 
funnel method. The blend was allowed to pour through a 
funnel that can be raised vertically until a maximum cone 
height (h) was obtained. The height of the funnel was adjust 
in such a way that the tip of the funnel just touch the apex of 
the powder blend. The powder blend was allow to flow 
through the funnel freely on the surface. The diameter of the 
powder cone was measured and the angle of repose was 
calculated using the following equation. Radius of heap (r) 
was measured and angle of repose (ϴ) was calculated using 
the formula [12]. 
ϴ = tan-1 height /radius 
Formulation of Sustained Release Tablets of Metformin 
Hydrochloride by wet granulation method Drug was 
accurately weighed and passed through # 40 sieve. The 
screened powder was transferred into the mortar pestle and 
mixed for 5 minutes. The corresponding amounts of 
polymers (Methocel K4M, guar gum, Xanthan gum, and Aloe 
Vera powder) and microcrystalline cellulose were accurately 
weighed, screened through screen # 40, added to mortar 
pestle and mixed. 5% alcoholic solution (IPA) of polyvinyl 
pyrrolidone (PVP K30) was then added to the powder 
mixture as binder forms a wet mass consistency. The wet 
mass was passed through a # 10 sieve and the resulting 
granules were placed on trays for drying into the oven at 
50°C for 10 minutes. The dried granules were passed 
through # 22 sieve. The dried granules and the 
corresponding amount of magnesium stearate, talc, and 
aerosil were accurately weighed and then mixed properly. 
Mixture was compressed into tablets using an instrumental 
tablet press and tablets were collected during compression 
for in process testing (weight and hardness) [2]. 
Separation of Aloe gel powder from fresh leaves of Aloe 
Vera 
Freshly cut leaves of Aloe barbadensis were washed 
thoroughly with water to remove the debris of soil and then 
cut open to collect the inner parenchymatous tissue (gel) of 
the leaf. The gel was then washed with distilled water and air 
dried under ambient condition for 12 hours and then at 80°C 
in a tray dryer for 4 hours to get solid dry mass. Dried solid 
mass was then converted into fine powder by mechanical 
grinding and passed through sieve # 85.  
At the end it was decided to prepare final batches F-7, F-8 
and F-9 with the combination of above polymers i.e. guar 
gum, xanthan gum, methocel K4M and finally the most 
suitable natural mucilage powder of Aloe Vera with the 
increasing ratios with respect to the quantity of drug i.e. (1:1, 
1:1.5, and 1:2). The other three polymers were kept in the 
same quantity for these three final batches as depicted in the 
table 3 and 4 [9]. 
Role of combination of the polymers in the final batches 
The maximum release or the ability to sustain small amount 
of drug with the three mention polymers can be attributed to 
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the effect of sudden erosion of the matrix after the swelling 
of these natural polymers. As high viscosity Methocel K4M is 
able to attribute to high gel layer formation which serves as a 
protective barrier to both the influx of water and the efflux of 
the drug in the solution. Aloe Vera contributes to both the 
formation of gel layer and the chain entanglement which 
provides higher resistance to the drug release for sufficient 
period of time. Another synergistic and potentiating effect 
contributed by the Aloe Vera is its anti-diabetic effect thus 
making the drug more patients compliant. Guar gum and 
xanthan gum contributes their swelling and gel forming 
properties with the time independent controlled release by 
providing surface erosion of matrix.  
Swelling index: 
The extent and degree of swelling was measured in terms of 
% (percentage) weight gain by the tablet. The swelling 
behaviors of the formulations were studied. One tablet from 
each formulation was kept in a petridish containing pH 6.8 or 
7.4 phosphate buffer, as the drug also shows good solubility 
in these both two. At the end of 1 h, the tablet was 
withdrawn, soaked with tissue paper, and weighed. Then 
after every 2 hours, weight gained by the tablets was noted, 
and this process was continued till the end of 12 hours. The 
percentage weight gain by the tablet was calculated by the 
following formula. 
% Swelling index = Mt- Mo /Mo×100 
Where, Mt = Wt. of tablet at time “t”. 
             Mo = Wt. of tablet at time, t = 0. 
 
Table 3: Formulation composition of matrix tablet (F- 1 to F - 4) 
Ingredients name (mg) F - 1 F - 2 F - 3 F - 4 
Metformin Hydrochloride 40 40 40 40 
Guar gum 20 30 - - 
Xanthan gum - - 20 30 
Methocel K4M - - - - 
Aloe Vera - - - - 
Polyvinyl pyrrolidone 12.5 12.5 12.5 12.5 
Microcrystalline cellulose 60 50 60 50 
Talc 50 50 50 50 
Aerosil 17.5 17.5 17.5 17.5 
 
Table 4: Formulation composition of matrix tablet (F - 5 to F - 9) 
Ingredients name (mg) F - 5 F - 6 F - 7 F - 8 F - 9 
Metformin Hydrochloride 40 40 40 40 40 
Guar gum - - 10 10 10 
Xanthan gum - - 10 10 10 
Methocel K4M 20 30 10 10 10 
Aloe Vera - - 50 50.5 60 
Polyvinyl pyrrolidone 12.5 12.5 12.5 12.5 12.5 
Microcrystalline cellulose 60 50 30 30 30 
Talc 50 50 20 20 16 
Aerosil 17.5 17.5 17.5 17 11.5 
 
Evaluation of tablets 
Post Compression parameters 
Appearance: The tablet must be free from cracks, 
depressions etc. The color and the polish must be uniform 
on the whole surface of tablet. The tablets should be smooth 
from all surfaces. [10]. 
Uniformity of weight 
Weight variation was carried out to check that whether each 
of the tablets contains the proper amount of drug. The test 
was performed by weighing the 20 tablets individually with 
the help of analytical balance, then the average weight was 
calculated and finally the comparison of the individual tablet 
weights to the average was done. The percentage of weight 
variation was calculated by applying the following formula. 
                                  % of wt. variation = Individual wt. – 
Average wt. /Average wt. ×100 
Hardness: 
The hardness of the tablet is defined as the load required 
crushing or fracture a tablet placed on its edge. Sometime it 
is also termed as tablet crushing strength. The hardness test 
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was performed using Monsanto type hardness tester. The 
crushing strength test was performed on 6 tablets from each 
formulation. The hardness was measured in terms of kg/cm2 
[10]. 
Friability: 
For each batch of formulation the friability of 20 tablets was 
determined by using Roche type friabilator. The device 
subjects to the combined effect of abrasion and shock in a 
plastic chamber revolving at a speed of 25 rpm for 4 min and 
dropping the tablets at a height of 6 inch in each revolution. 
Preweighed sample of tablets were placed in the friabilator 
and then subjected to 100 revolutions. 
Tablet thickness: 
Tablet thickness is particular in reproducing appearance as 
well as in counting by using filling equipment. Some filling 
equipment devices presumes the uniform thickness of the 
tablets as a counting mechanism. Ten tablets were taken and 
their thickness was recorded using micrometer [11]. 
 Drug content uniformity: 
The four tablets from each batch were randomly selected, 
weighed and then crushed in mortar. The powder equivalent 
to 10mg were weighed and dissolved in 50 ml methanol, 
from this solution 1 ml solution was again diluted to 10 ml 
with methanol. From this diluted solution was taken and 
further diluted up to 10 ml with methanol and assayed for 
drug content at 233 nm using blank as standard solution. 
In vitro dissolution studies: 
Drug release studies were conducted using USP dissolution 
apparatus I, basket type (Electro lab, Mumbai, India) at a 
rotational speed of 100 rpm at 37±0.5 ºC. The dissolution 
media used were 900 mL of pH 6.8 phosphate buffer 
solutions for 12 hrs. Sink condition was maintained for the 
whole experiment. Samples usually 10 ml were withdrawn 
at regular intervals of time and the same volume of 
prewarmed (37±0.5 ºC) fresh dissolution medium was used 
to replace in order to maintain the volume constant. The 
samples withdrawn were further evaluated for drug content 
in each sample after suitable dilution with 
spectrophotometer. These were analyzed at 233nm [13]. 
Total nine formulations of sustained release tablets of 
Metformin Hydrochloride were made and composed of 
following ratios of polymers as given in the tables 5 and 6 
and their dissolution rate profiles were checked at different 
intervals of time. The values of in vitro drug release are 
depicted in the Table 7 and 8. 
The % of drug release was calculated from the given formula 
Amount of drug release (mg) = (Concentration   Dilution 
factor  Volume of dissolution medium)/ 1000 
% drug release = Amount of drug released (mg)   100/ dose 
(mg) [14] 
RESULTS AND DISCUSSION 
Results 
Determination of absorption maxima 
The absorption maxima of Metformin Hydrochloride in 
phosphate buffer of pH was found to be 233.00nm which 
successfully resembled with pharmacopoeial standards.
 
 
Figure 1: U.V graph showing bell Shaped curve of Metformin Hydrochloride during its calibration. 
 
Figure 2: Absorption maxima of Metformin Hydrochloride. 
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Table 5: Standard curve data of metformin hydrochloride in saline phosphate buffer pH (6.8) 
 
 
 
Figure 3: Standard curve of Metformin HCl in saline phosphate buffer of pH 6.8. 
 
Table 6: The statistical parameters related to standard curve of metformin hydrochloride in saline phosphate buffer 
pH (6.8) 
Sr. No. Parameters Values 
1. Regression Coefficient 0.995 
2. Equation of line 0.069x + 0.0119 
 
As it is clearly depicted from the graph of figure that the value of regression coefficient for Metformin Hydrochloride is 0.995, 
which clearly demonstrates and proves the linear analysis of standard curve of drug.  
 
Table 7:  Cumulative % drug release of formulations of sustained release tablets (F-1 to F-4). 
Time (min.) F-1 F-2 F-3 F-4 
0 0 0 0 0 
30 12.1 13.4 11.1 9.2 
60 26.1 24.10 22.09 38.22 
120 48.11 48.12 44.06 40.44 
180 60.10 60.16 58.10 52.7 
240 78.09 74.32 72.12 64.12 
300 88.11 80.56 78.32 72.31 
360 92.15 88.55 84.42 84.62 
420 94.44 92.22 89.54 88.45 
480 94.54 92.21 94.12 92.55 
540 94.62 92.50 94.18 92.52 
600 94.22 92.26 94.20 92.25 
660 94.83 92.33 94.27 92.63 
720 94.19 92.44 94.45 94.64 
 
 
Sr. No. Concentration (µg/ml) Absorbance (nm) 
1. 1 0.101 
2. 2 0.158 
3. 3 0.212 
4. 4 0.259 
5. 5 0.356 
6. 6 0.417 
7. 7 0.498 
8. 8 0.560 
9. 9 0.645 
10. 10 0.707 
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Table 8: Cumulative % drug release of formulations of sustained release tablets (F-5 to F-9). 
Time (min.) F-5 F-6 F-7 F-8 F-9 
0 0 0 0 0 0 
30 8.4 8.9 6.2 6.3 6.5 
60 36.16 25.42 12.40 10.12 10.12 
120 40.22 36.55 26.36 23.65 24.12 
180 50.21 42.66 38.45 31.36 32.33 
240 59.12 55.16 44.48 39.45 39.27 
300 70.31 62.18 54.56 48.11 49.62 
360 82.44 69.12 66.35 60.32 60.14 
420 86.55 78.20 78.75 72.21 70.84 
480 91.41 89.22 88.58 79.12 79.45 
540 91.22 90.32 94.14 88.66 86.32 
600 93.33 94.44 94.55 94.45 96.55 
660 94.46 94.45 94.45 94.40 96.68 
720 94.47 94.55 94.65 94.44 97.77 
  
 
Figure 4: In vitro dissolution profiles of Metformin Hydrochloride of batches (F-1 to F-9). 
Table 9: Results of precompression parameters of powder blends of Metformin Hydrochloride 
Formulations Angle of 
repose 
Bulk density Tapped 
density 
Carr’s index Hausner’s 
ratio 
F-1 33.4±0.03 0.415±0.01 0.445±0.04 13.75±0.02 1.161±0.02 
F-2 28.8±0.04 0.422±0.02 0.443±0.03 10.44±0.03 1.182±0.02 
F-3 29.7±0.04 0.409±0.02 0.451±0.02 13.91±0.02 1.151±0.03 
F-4 25.4±0.03 0.318±0.02 0.363±0.07 13.47±0.01 1.189±0.01 
F-5 26.4±0.02 0.317±0.01 0.372±0.02 14.45±0.02 1.178±0.02 
F-6 33.2±0.02 0.319±0.03 0.370±0.02 13.89±0.02 1.142±0.04 
F-7 29.0±0.03 0.320±0.02 0.362±0.03 12.68±0.02 1.168±0.03 
F-8 27.8±0.04 0.323±0.02 0.442±0.04 13.46±0.02 1.178±0.03 
F-9 26.4±0.02 0.317±0.01 0.365±0.04 14.45±0.01 1.180±0.02 
 
Table 10: Results of Post compression parameters of punched tablets of Metformin Hydrochloride 
Formulations Weight variation of 
tablet (mg) 
Hardness 
(kg/cm2) 
Thickness 
    (mm) 
Friability 
(%) 
F-1 202.15±1.73 5.64±0.45 3.42±0.48 0.59 
F-2 201.55±1.54 5.58±0.40 3.49±0.15 0.49 
F-3 202.0±1.45 5.44±0.36 3.54±0.20 0.78 
F-4 201.9±1.65 5.60±0.33 3.48±0.14 0.44 
F-5 201.65±1.46 5.63±0.38 3.44±0.15 0.34 
F-6 201.6±1.39 5.53±0.31 3.55±0.24 0.69 
F-7 201.8±1.70 5.57±0.31 3.58±0.21 0.73 
F-8 201.5±1.50 5.49±0.24 3.55±0.23 0.59 
F-9 201.65±1.53 5.59±0.29 3.59±0.19 0.44 
The post compression parameters of compressed batches was found within acceptable limits as per according U.S.P limits. 
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Table 11: Drug content uniformity of tablet batches 
Formulations Drug content (%) 
F-1 99.7% 
F-2 99.41% 
F-3 99.48% 
F-4 100.12% 
F-5 96.50% 
F-6 98.79% 
F-7 98.84% 
F-8 99.79% 
F-9 99.93% 
 
 
Curve fitting analysis of in vitro dissolution studies 
The dissolution data obtained for best F-9 formulation was 
fitted to various kinetic models like Zero order, First order, 
and Higuchi, Korsmeyer and Peppas models in order to know 
the mechanism of drug release from matrix of tablet which is 
usually made of hydrophilic polymers. The results are shown 
below.
 
Table 12: Zero order kinetics of F-9 formulation 
Sr. No. Time % Cumulative drug release 
1). 0 0 
2). 30 6.5 
3). 60 10.12 
4). 120 24.12 
5). 180 32.33 
6). 240 39.27 
7). 300 49.62 
8). 360 60.14 
9). 420 70.84 
10). 480 79.45 
11). 540 86.32 
12). 600 96.55 
13). 660 96.68 
14). 720 97.77 
 
 
Figure 5: Graph of Zero order kinetics of best formulation of F-9. 
 
 
 
 
Sharma et al                                                                                                         Journal of Drug Delivery & Therapeutics. 2019; 9(3-s):374-385 
ISSN: 2250-1177                                                                                   [382]                                                                                     CODEN (USA): JDDTAO 
Table 13: First order kinetics of F-9 formulation 
Sr. No. Time (min.) Log % cumulative drug retained 
1). 0 2 
2). 30 1.970 
3). 60 1.953 
4). 120 1.880 
5). 180 1.830 
6). 240 1.783 
7). 300 1.702 
8). 360 1.600 
9). 420 1.464 
10). 480 1.312 
11). 540 1.136 
12). 600 0.537 
13). 660 0.521 
14). 720 0.348 
   
Log% cumulative drug retained was calculated by subtracting the cumulative drug release from 100 and then taking the 
logarithm of obtained value. 
 
Figure 6: Graph of First order kinetics of F-9. 
 
Table 14: Higuchi kinetics of F-9 formulation 
Sr. No. Square root of time % Cumulative drug release 
1). 0 0 
2). 5.477 6.5 
3). 7.745 10.12 
4). 10.954 24.12 
5). 13.416 32.33 
6). 15.491 39.27 
7). 17.320 49.62 
8). 18.973 60.14 
9). 20.493 70.84 
10). 21.908 79.45 
11). 23.237 86.32 
12). 24.494 96.55 
13). 25.690 96.68 
14). 26.832 97.77 
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Figure 7: Graph of Higuchi kinetics of F-9. 
 
As the regression coefficient values for Zero order and First 
order were found to be 0.98 and 0.89 with high linearity and 
release of drug from matrix made of hydrophilic polymers 
involves the factors of diffusion. Diffusion is related to 
transport of drug from a matrix into the in vitro study fluid, 
which in turn depends on the concentration. As the 
concentration gradient increases, the drug is released and 
the distance for diffusion gradually increases finally the drug 
diffuses at a comparatively slower rate as the distance for 
diffusion increases. This phenomenon is preferred to as 
square root kinetics or Higuchi kinetics.  
 
Table 15: Korsmeyer and Peppas kinetics of F-9 formulation 
Sr. No. Log time Log % Cumulative drug release 
1). 0 0 
2). 1.477 0.812 
3). 1.788 1.005 
4). 2.079 1.382 
5). 2.255 1.509 
6). 2.380 1.594 
7). 2.477 1.695 
8). 2.556 1.779 
9). 2.623 1.850 
10). 2.681 1.900 
11). 2.732 1.936 
12). 2.778 1.984 
13). 2.819 1.985 
14). 2.857 1.990 
 
 
Figure 8: Graph of Korsmeyer Peppas of F-9 formulation. 
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Results of flow properties of Aloe barbadensis powder 
The viscosity of 1% gum solution in water was found to be 
8.54 poise indicating viscous flow of gel. But the gum was 
made to dry with the help of tray dryer, and the powder was 
obtained. 
Table 16: Flow properties of Aloe barbadensis powder 
Sr. No. Parameters Value 
1). Bulk density (g/ml) 0.35 
2). Tapped density (g/ml 0.39 
3). Carr’s index (%) 13.17 
4). Hausner’s ratio 1.13 
5). Angle of repose 23° 
 
After seeing the in vitro release data of all formulation 
batches it was demonstrated that the F-9 was considered as 
the best formulation because it was capable to release the 
drug in the sustained manner with respect to time as 
compared to others. The cumulative % drug release was also 
found to be maximum in the 12 hours with this formulation 
i.e. 97.77%. Due to the complete release of drug within 12 
hours the effect of the drug can be seen throughout the day, 
thus eliminating the intake of another dose of drug in the 
same day. F-9 formulation composition also served to be 
very effective as it contains high ratio of Aloe barbadensis i.e. 
1:2 (60mg) while all other used polymers ratio was kept 
constant throughout the process. 
The regression coefficient “r” value of zero order and first 
order were 0.982 and 0.894. The regression coefficient “r” 
value for Higuchi and Korsmeyer and Peppas were found to 
be 0.95 and 0.98. It indicated that the release of drug from 
these sustained formulations was governed by diffusion 
controlled process. The value of “n” was found to be 0.742 
indicating the anomalous non Fickian diffusion as it is 
depicted from the Korsmeyer and Peppas model graph of 
figure 8. The “n” is responsible for depicting the type of 
diffusion.
  
Stability studies 
Table 17: Accelerated stability study of matrix tablets of Metformin HCl of batch F-9 at 40°C and 75% Relative 
humidity. 
Sr. No. Parameter Initial 1 month 2 month 3 month 
1). Average weight (mg) 201.65 201.67 201.69 201.69 
2). Friability (%) 0.44 0.43 0.43 0.43 
3). Hardness (Kg/cm2) 5.59±0.29 5.49±0.29 5.49±0.29 5.40±0.01 
4). %Drug release (up to 12 hours) 97.77 97.62 97.62 97.62 
   
The stability study on the final and best formulation F-9 indicated that there was slight acceptable differences in average 
weight, friability, hardness and in vitro drug dissolution after 3 months at 40°C/75% RH [8]. 
Swelling index 
 
Figure 9: Graph of swelling index of formulations F-1 to F-9. 
 
DISCUSSION 
In the matrix tablet, Xanthan gum, Guar gum, Aloe 
barbadensis and Methocel K4M were used as retarding 
agent. And the study showed that Aloe barbadensis 
satisfactorily proved to be best pharmaceutical excipient in 
the formulation and manufacture of sustained release matrix 
tablets because of its high viscosity and capability to form a 
gelatinous layer around tablet core. The dried mucilage was 
capable to undergo sufficient swelling and entanglement of 
polymeric chains. Thus F-9 formulations which consist of 
highest ratio of Aloe barbadensis with the combination of 
other three polymers provides sustained release of drug 
with 6.5% of drug release within 1 hour and finally 97.7% of 
drug release within 12 hours, maximum for therapeutic 
effect to occur. The combinational composition of 
hydrophilic polymers provides the formation of original 
protective gel layer which controls the penetration of water 
into the tablet. As the outer gel layer fully hydrates and 
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dissolves, consequently a new inner layer must replace it 
and be cohesive as well as continuous enough to retard the 
influx of water and control of drug diffusion. Aloe 
barbadensis was chosen to be best fit polymer or natural 
gum because of its excellent anti-diabetic effect which 
combats all the side effects of Metformin such as G.I.T 
symptoms and thus provides synergistic action to drug. 
CONCLUSION 
Metformin Hydrochloride is used as an anti-diabetic drug. In 
the present research work the sustained release tablet was 
successfully formulated and studied by using different 
polymers by utilizing the wet granulation method. From in 
vitro dissolution profile analysis data the following 
conclusions were drawn out. Formulation batches F-1 and F-
2 were composed of 20% and 30% of guar gum, released the 
26.1% and 24.10% of drug respectively in 60 minutes (1 
hour). Formulation batches F-3 and F-4 were composed of 
20% and 30% of xanthan gum, released the 22.09% and 
38.22% of drug respectively in 60 minutes. F-5 and F-6 were 
composed of 20% and 30% of methocel K4M, released the 
36.16% and 25.12% of drug in 60 minutes. The F-7, F-8 and 
F-9 were composed of Aloe barbadensis with other three 
previously used polymers in the constant or same quantity. 
Aloe vera was composed in the following ratio of 1:1, 1:1.5 
and 1:2. The release rates of these formulations were 6.2%, 
6.3% and 6.5% in 60 minutes (1 hour). The release rates of 
the formulation batches F-1 to F-6 were high due to the use 
of hydrophilic polymers (xanthan gm, guar gum and 
methocel K4M) alone in these batches. The use of these 
polymers alone for the purpose of extending drug release for 
highly water soluble drugs is restricted due to rapid 
diffusion of the dissolved drug through the hydrophilic gel 
network. As these polymers are known to possess low 
viscosity as compared to Aloe barbadensis mucilage. It was 
found that by increasing the viscosity of polymer as 
observed in F-9 formulation, the retarding rate can be 
proportionately increased. Therefore F-9 was opted to be an 
optimized formulation thus it was fitted to regression 
analysis data of various models, the “r” values Higuchi model 
and Korsmeyer and Peppas model were 0.95 and 0.98 which 
indicated diffusion mechanism for drug release. Higuchi 
kinetics is also called as square root kinetics which is 
responsible for explaining the drug diffusion which occurs at 
comparatively slower rate when the distance for diffusion 
increases. The “n” value of F-9 was found to be 0.742 which 
indicated anomalous or non- Fickian diffusion mechanism 
for the drug release. After compilation of these values it was 
concluded that rug follows both diffusion and erosion 
mechanism for its release.  
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